Enliven Therapeutics (NASDAQ:ELVN) on Thursday filed a prospectus related to the proposed resale of about 6.43M shares of its ...

Enliven Therapeutics shares rose after the company said it saw positive proof of concept data from a Phase 1 clinical trial evaluating ELVN-001 in patients with a type of blood cancer. Shares were ...

While visitors on Oaks and Derby Days transform part of Louisville’s South End, thousands of residents call the area home all ...

Analyst Salim Syed from Mizuho Securities maintained a Buy rating on Enliven Therapeutics (ELVN – Research Report) and keeping the price ...

Investors considering a purchase of Enliven Therapeutics Inc (Symbol: ELVN) stock, but cautious about paying the going market price of $16.61/share, might benefit from considering selling puts ...

April 11, 2024 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage precision oncology company focused on the discovery and development of next ...

The Latino Community Projects group's sixth annual Cinco de Mayo Festival is scheduled for downtown Fremont Saturday from 11 ...

Tourists to Hong Kong have long been fed rote-learned clichés about its history by uninspiring and uninspired guides. In ...

Just in time for the West Virginia Strawberry Festival, the Fred Brooks Garden Club is ready to begin its annual Yards of the Month program. The first award given out in May will be the “Strawberry ...

April 11, 2024 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage precision oncology company focused on the discovery and development of next ...

“We are thrilled with ELVN-001’s initial Phase 1 data in heavily pre-treated patients with CML,” said Sam Kintz, Co-founder and Chief Executive Officer of Enliven. “We believe that with ...

ELVN-001 is a potent, highly selective, potentially best-in-class small molecule kinase inhibitor designed to specifically ...